Showing results (171-180 of 207) with videos related to

Sort By:
Pageof 21
International Journal of Hematology|October 21, 2025
Peripheral T cell lymphoma following CD19-targeted chimeric antigen receptor T cell therapyHiro Tatetsu, Koji Kato, Atsushi Wada, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|April 1, 2026
CD5-positive diffuse large B-Cell lymphoma presenting with protein-losing enteropathyKenji Moriwaki, Hiro Tatetsu, Yusuke Higuchi, et al.
International Cancer Conference Journal|April 8, 2020
Renal metastasis from intrahepatic cholangiocarcinomaChihiro Matsumoto, Katsunori Imai, Yosuke Nakao, et al.
Brain Tumor Pathology|May 21, 2022
Diffusely infiltrating glioma with CREBBP-BCORL1 fusion showing overexpression of not only BCORL1 but BCOR: A case reportAyako Yamazaki, Yasuhito Arai, Kohei Fukuoka, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|October 28, 2022
Data Set for the Reporting of Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma: Recommendations From the International Collaboration on Cancer Reporting (ICCR)C Blake Gilks, Christina I Selinger, Ben Davidson, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 24, 2026
Conversion Hepatectomy After New FP Therapy for Malignant Hepatocellular Neoplasm, Not Otherwise Specified: A Case ReportEtsuko Moriyama, Hironori Koga, Takashi Niizeki, et al.
Cancer Science|February 8, 2025
Abnormal Vessels Potentially Accelerate Glioblastoma Proliferation by Inducing the Protumor Activation of MacrophagesHiroaki Matsuzaki, Keitaro Kai, Yoshihiro Komohara, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 20, 2015
Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)W Glenn McCluggage, Meagan J Judge, Blaise A Clarke, et al.
Brain Tumor Pathology|April 22, 2023
Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitorsNaoki Shinojima, Kazutaka Ozono, Haruaki Yamamoto, et al.
Pageof 21